Ads
related to: betaseron plusthorne.com has been visited by 10K+ users in the past month
Search results
Results from the Go Local Guru Content Network
Interferon beta-1b is a cytokine in the interferon family used to treat the relapsing-remitting and secondary-progressive forms of multiple sclerosis (MS). It is approved for use after the first MS event. Closely related is interferon beta 1a, also indicated for MS, with a very similar drug profile.
Betaseron/Betaferon: Bayer HealthCare 7: $876 million: Dimethyl fumarate: Tecfidera: Biogen Idec 8: $303 million: 4-Aminopyridine: Ampyra: Acorda Therapeutics: 9: $250 million: Adrenocorticotropic hormone: H.P. Acthar Gel: Questcor Pharmaceuticals 10: $221 million: Teriflunomide: Aubagio: Sanofi
Interferon type I (α/β/δ...) Interferons ( IFN s, / ˌɪntərˈfɪərɒn / IN-tər-FEER-on [1]) are a group of signaling proteins [2] made and released by host cells in response to the presence of several viruses. In a typical scenario, a virus-infected cell will release interferons causing nearby cells to heighten their anti-viral defenses.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
This was followed a year later by Betaseron, a beta interferon, the first treatment for relapsing-remitting multiple sclerosis and made by Berlex Laboratories Inc. In 1997 Chiron provided the active ingredient, becaplermin, in Regranex, a topical treatment for diabetic foot ulcers, manufactured by Ortho-McNeil Pharmaceutical Inc. In 2001 ...
Specialty. Neurology. Parkinson-plus syndromes ( PPS) are a group of neurodegenerative [1] diseases featuring the classical features of Parkinson's disease ( tremor, rigidity, akinesia / bradykinesia, and postural instability) with additional features that distinguish them from simple idiopathic Parkinson's disease (PD).
Ad
related to: betaseron plus